The growing burden of diabetes mellitus in the US elderly population.
暂无分享,去创建一个
Frank A Sloan | M. Feinglos | F. Sloan | M. A. Bethel | A. M. Shea | M Angelyn Bethel | Alisa M Shea | Mark N Feinglos | David Ruiz | David Ruiz
[1] Michael J. Pencina,et al. Trends in the Incidence of Type 2 Diabetes Mellitus From the 1970s to the 1990s: The Framingham Heart Study , 2006, Circulation.
[2] David M Nathan,et al. Tests of Glycemia for the Diagnosis of Type 2 Diabetes Mellitus , 2002, Annals of Internal Medicine.
[3] A. L'Abbate,et al. Association between increased mortality and mild thyroid dysfunction in cardiac patients. , 2007, Archives of internal medicine.
[4] F. L. Lucas,et al. Temporal Trends in the Utilization of Diagnostic Testing and Treatments for Cardiovascular Disease in the United States, 1993–2001 , 2006, Circulation.
[5] E. Vittinghoff,et al. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. , 2005, Archives of internal medicine.
[6] L. Ghiadoni,et al. Recombinant human thyrotropin reduces endothelium-dependent vasodilation in patients monitored for differentiated thyroid carcinoma. , 2006, The Journal of clinical endocrinology and metabolism.
[7] J. Pankow,et al. Apolipoprotein E and progression of chronic kidney disease. , 2005, JAMA.
[8] Charles Maynard,et al. Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans. , 2003, Diabetes care.
[9] B. Yawn,et al. Identifying Persons with Diabetes Using Medicare Claims Data , 1999, American journal of medical quality : the official journal of the American College of Medical Quality.
[10] M. Engelgau,et al. Changes in incidence of diabetes in U.S. adults, 1997-2003. , 2006, American journal of preventive medicine.
[11] Betsy L Cadwell,et al. Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the U.S. , 2004, Diabetes care.
[12] P. Raskin,et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.
[13] Frank A Sloan,et al. Longitudinal incidence and prevalence of adverse outcomes of diabetes mellitus in elderly patients. , 2007, Archives of internal medicine.
[14] N. Powe,et al. Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. , 2000, The Journal of clinical endocrinology and metabolism.
[15] J. Xue,et al. Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause? , 2005, Kidney international.
[16] G. Eknoyan,et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). , 2005, Kidney international.
[17] K. A. Thomas,et al. Measures of Disease Control in Medicare Beneficiaries with Diabetes Mellitus , 1999, Journal of the American Geriatrics Society.
[18] L. Ghiadoni,et al. Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto's thyroiditis. , 2006, The Journal of clinical endocrinology and metabolism.
[19] Haiqing Zhang,et al. Subclinical hypothyroidism , 2009 .
[20] A. Fraser,et al. Subclinical hypothyroidism, arterial stiffness, and myocardial reserve. , 2006, The Journal of clinical endocrinology and metabolism.
[21] Ralph B D'Agostino,et al. Trends in cardiovascular complications of diabetes. , 2004, JAMA.
[22] Peter O'Leary,et al. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. , 2005, Archives of internal medicine.
[23] A. Brett. Can We Prevent Type 2 Diabetes , 2001 .
[24] A. Morris,et al. The annual incidence of diabetic complications in a population of patients with Type 1 and Type 2 diabetes , 2005, Diabetic medicine : a journal of the British Diabetic Association.
[25] T. Buchanan. (How) Can We Prevent Type 2 Diabetes? , 2007, Diabetes.
[26] C. Palombo,et al. Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study. , 2004, The Journal of clinical endocrinology and metabolism.
[27] Giuseppe Remuzzi,et al. Nephropathy in Patients with Type 2 Diabetes , 2002 .
[28] J. Leahy. Mortality Trends in Men and Women with Diabetes, 1971 to 2000 , 2008 .
[29] B. Virnig,et al. The Medicare-HMO revolving door--the healthy go in and the sick go out. , 1997, The New England journal of medicine.
[30] E. Ritz,et al. Nephropathy in patients with type 2 diabetes mellitus. , 1999, The New England journal of medicine.
[31] S. Haffner,et al. Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study. , 1999, Archives of internal medicine.
[32] M. Alevizaki,et al. High serum cholesterol levels in persons with 'high-normal' TSH levels: should one extend the definition of subclinical hypothyroidism? , 1998, European journal of endocrinology.
[33] A. Hofman,et al. Subclinical Hypothyroidism Is an Independent Risk Factor for Atherosclerosis and Myocardial Infarction in Elderly Women: The Rotterdam Study , 2000, Annals of Internal Medicine.
[34] J. Weaver,et al. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. , 2007, The Journal of clinical endocrinology and metabolism.
[35] J. Franklyn,et al. Thyroid function and mortality in patients treated for hyperthyroidism. , 2005, JAMA.
[36] M. Harris. Medical Care for Patients with Diabetes: Epidemiologic Aspects , 1996, Annals of Internal Medicine.
[37] J. Mehlsen,et al. Hemodynamic changes after levothyroxine treatment in subclinical hypothyroidism. , 2002, Thyroid : official journal of the American Thyroid Association.
[38] E. McGlynn,et al. The quality of health care delivered to adults in the United States. , 2003, The New England journal of medicine.
[39] J. Franklyn,et al. Association between serum free thyroxine concentration and atrial fibrillation. , 2007, Archives of internal medicine.
[40] G. Meneilly,et al. Diabetes in elderly adults. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.
[41] L. Ghiadoni,et al. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. , 2003, The Journal of clinical endocrinology and metabolism.
[42] J. Crews,et al. Public health and aging. , 2003, American journal of public health.
[43] E. Mazzaferri. Thyroid Status, Cardiovascular Risk, and Mortality in Older Adults , 2007 .
[44] L. Melton,et al. Effects of Changing Diagnostic Criteria on the Risk of Developing Diabetes , 1998, Diabetes Care.
[45] A. de Leiva,et al. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? , 1998, Diabetologia.
[46] J. Leahy,et al. Improvements in Diabetes Processes of Care and Intermediate Outcomes: United States, 1988–2002Saaddine JB, Cadwell B, Gregg EW, et al (Centers for Disease Control and Prevention, Atlanta, Ga) Ann Intern Med 144:465–474, 2006§ , 2007 .